Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - ethinylestradiol 2.7mg (15µg/24h elution rate in-vivo);  ; etonogestrel 11.7mg (120µg/24h elution rate in-vivo);   - vaginal ring - 120mcg etonogestrel, 15mcg ethinylestradiol / 24h - active: ethinylestradiol 2.7mg (15µg/24h elution rate in-vivo)   etonogestrel 11.7mg (120µg/24h elution rate in-vivo)   excipient: evatane 1020 vn3 ethylene/vinyl acetate co-polymer evatane 28-25 ethylene/vinyl acetate co-polymer magnesium stearate - contraception.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinylestradiol,levonorgestrel -

Australie - anglais - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinylestradiol,levonorgestrel -

Australie - anglais - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinylestradiol,levonorgestrel -

Malte - anglais - Medicines Authority

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - ethinylestradiol - gastro-resistant tablet - ethinylestradiol 10 microgram(s) - sex hormones and modulators of the genital system

Malte - anglais - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - ethinylestradiol - gastro-resistant tablet - ethinylestradiol 10 µg - sex hormones and modulators of the genital system

Malte - anglais - Medicines Authority

merck sharp & dohme limited hertford road, hoddesdon, hertfordshire en11 9bu, united kingdom - ethinylestradiol, etonogestrel - vaginal delivery system - ethinylestradiol 2.7 milligram(s) ; etonogestrel 11.7 milligram(s) - other gynecologicals

Malte - anglais - Medicines Authority

n.v. organon kloosterstraat 6, nl-5349 ab oss, netherlands - ethinylestradiol, etonogestrel - vaginal delivery system - ethinylestradiol 2.7 mg etonogestrel 11.7 mg - other gynecologicals

Australie - anglais - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - ethinylestradiol, quantity: 20 microgram; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: maize starch; lactose monohydrate; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - bella is indicated for use:,? as an oral contraceptive.,? for the treatment of moderate acne vulgaris in women who seek oral contraception.,? for the treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of ethinylestradiol/drospirenone 20 microgram/3 mg tablets for pmdd was not assessed beyond 3 cycles. ethinylestradiol/drospirenone 20 microgram/3 mg tablets have not been evaluated for treatment of pms (premenstrual syndrome) (see section 5.1 pharmacodynamic properties ? clinical trials).

Irlande - anglais - HPRA (Health Products Regulatory Authority)

gedeon richter plc - ethinyloestradiol; levonorgestrel; levonorgestrel; ethinylestradiol; levonorgestrel; ethinylestradiol - coated tablet - . milligram(s) - progestogens and estrogens, sequential preparations; levonorgestrel and ethinylestradiol